Examining a Novel FDA-approved Therapy in Desmoid Tumors
FDA approval of Nirogacistat for desmoid tumors highlights improved survival rates, quality of life, and manageable side effects for patients.
Novel Pharmacotherapies and NCCN Guideline Recommendations
Explore the evolving landscape of desmoid tumor treatments, including chemotherapy, tyrosine kinase inhibitors, and emerging clinical trials.
Surgery, Cryotherapy, and Radiotherapy for Desmoid Tumors
Explore the evolving landscape of desmoid tumor treatments, highlighting surgery, cryotherapy, and radiotherapy for effective patient care.
When to Observe Desmoid Tumors
Experts discuss the complexities of observing desmoid tumors, weighing the benefits of active surveillance against the need for immediate treatment.
The Burden and Unmet Needs Associated with Desmoid Tumors
Patients with desmoid tumors face significant clinical and economic burdens, impacting their quality of life and leading to ongoing treatment challenges.
The Role of Molecular Biomarkers in Diagnosing Desmoid Tumors
Explore the critical role of biomarkers in diagnosing desmoid tumors and the importance of early detection for patient quality of life.
Exploring the Heterogeneous Nature of Desmoid Tumors
Key Background Information on Desmoid Tumors
